Trials / Completed
CompletedNCT02073071
Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 139 (actual)
- Sponsor
- Abbott Nutrition · Industry
- Sex
- All
- Age
- 21 Days
- Healthy volunteers
- Not accepted
Summary
This is a two stage open-label, single-arm, multicenter and observational study.
Detailed description
Stage 1: In hospital, preterm/low birth weight infants less than or equal to 34 weeks gestational age at birth, birth weight of ≥ 1000g to \<1800g and conditions meeting the enrollment criteria will be fed formula with or without parenteral nutrition until discharge. Stage 2: Post-discharge, all infants with birth weight \< or =1500g will be followed on formula per standard of care and accepted standard of care including feeding until the infant's weight \>or= 25th percentile of growth expectation based on corrected age (P25) or until infant reaches 9 months corrected age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Preterm infant formula per standard of care | Commercially available preterm infant formula |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-09-01
- Completion
- 2015-11-01
- First posted
- 2014-02-27
- Last updated
- 2015-11-30
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02073071. Inclusion in this directory is not an endorsement.